Bioventus Stock Operating Margin

BVS Stock  USD 5.14  0.01  0.19%   
Bioventus fundamentals help investors to digest information that contributes to Bioventus' financial success or failures. It also enables traders to predict the movement of Bioventus Stock. The fundamental analysis module provides a way to measure Bioventus' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Bioventus stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Bioventus Operating Margin Analysis

Bioventus' Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
 2020 2021 2023 2024 (projected)
Change To Liabilities20.5M18.2M20.9M13.8M
Change To Netincome18.3M11.9M10.7M18.1M

Operating Margin

 = 

Operating Income

Revenue

X

100

More About Operating Margin | All Equity Analysis

Current Bioventus Operating Margin

    
  0.02 %  
Most of Bioventus' fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bioventus is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Bioventus Operating Margin Driver Correlations

Understanding the fundamental principles of building solid financial models for Bioventus is extremely important. It helps to project a fair market value of Bioventus Stock properly, considering its historical fundamentals such as Operating Margin. Since Bioventus' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Bioventus' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Bioventus' interrelated accounts and indicators.
0.730.860.170.89-0.220.90.870.110.930.820.970.820.610.97-0.660.83-0.570.660.710.920.970.430.86-0.89-0.7-0.23-0.23-0.23
0.730.33-0.490.79-0.60.910.69-0.590.510.690.840.630.620.81-0.570.74-0.430.50.540.80.64-0.220.86-0.75-0.86-0.46-0.46-0.46
0.860.330.440.670.190.580.60.530.890.630.720.540.390.79-0.670.66-0.690.360.50.70.90.630.52-0.72-0.44-0.08-0.08-0.08
0.17-0.490.44-0.140.44-0.20.210.850.370.080.030.27-0.15-0.030.23-0.090.240.260.24-0.060.220.92-0.060.010.330.360.360.36
0.890.790.67-0.14-0.420.930.81-0.130.850.810.90.750.710.89-0.770.9-0.640.620.660.980.890.150.87-0.93-0.59-0.39-0.39-0.39
-0.22-0.60.190.44-0.42-0.45-0.540.73-0.17-0.54-0.35-0.56-0.43-0.180.14-0.58-0.16-0.58-0.41-0.47-0.220.28-0.60.520.190.790.790.79
0.90.910.58-0.20.93-0.450.84-0.270.750.760.960.770.690.94-0.60.8-0.50.670.620.920.830.050.91-0.84-0.81-0.29-0.29-0.29
0.870.690.60.210.81-0.540.84-0.040.850.830.90.990.570.77-0.380.81-0.160.920.80.880.860.420.92-0.87-0.51-0.37-0.37-0.37
0.11-0.590.530.85-0.130.73-0.27-0.040.31-0.12-0.09-0.04-0.23-0.020.06-0.17-0.11-0.03-0.05-0.120.190.75-0.30.10.340.490.490.49
0.930.510.890.370.85-0.170.750.850.310.830.850.830.50.83-0.660.84-0.520.680.740.90.980.620.78-0.9-0.41-0.27-0.27-0.27
0.820.690.630.080.81-0.540.760.83-0.120.830.820.830.620.74-0.660.92-0.40.660.730.880.850.420.88-0.93-0.48-0.6-0.6-0.6
0.970.840.720.030.9-0.350.960.9-0.090.850.820.850.650.96-0.590.81-0.470.70.720.920.910.280.92-0.87-0.79-0.26-0.26-0.26
0.820.630.540.270.75-0.560.770.99-0.040.830.830.850.530.69-0.330.78-0.070.930.830.830.810.470.9-0.84-0.43-0.38-0.38-0.38
0.610.620.39-0.150.71-0.430.690.57-0.230.50.620.650.530.63-0.60.64-0.40.340.610.670.560.070.7-0.64-0.45-0.35-0.35-0.35
0.970.810.79-0.030.89-0.180.940.77-0.020.830.740.960.690.63-0.70.78-0.670.520.60.90.910.230.83-0.83-0.83-0.18-0.18-0.18
-0.66-0.57-0.670.23-0.770.14-0.6-0.380.06-0.66-0.66-0.59-0.33-0.6-0.7-0.780.9-0.06-0.5-0.75-0.71-0.1-0.590.760.430.460.460.46
0.830.740.66-0.090.9-0.580.80.81-0.170.840.920.810.780.640.78-0.78-0.570.620.70.950.890.230.86-0.99-0.48-0.71-0.71-0.71
-0.57-0.43-0.690.24-0.64-0.16-0.5-0.16-0.11-0.52-0.4-0.47-0.07-0.4-0.670.9-0.570.14-0.16-0.58-0.610.01-0.320.560.470.20.20.2
0.660.50.360.260.62-0.580.670.92-0.030.680.660.70.930.340.52-0.060.620.140.620.690.650.370.74-0.68-0.29-0.28-0.28-0.28
0.710.540.50.240.66-0.410.620.8-0.050.740.730.720.830.610.6-0.50.7-0.160.620.730.70.480.86-0.74-0.29-0.35-0.35-0.35
0.920.80.7-0.060.98-0.470.920.88-0.120.90.880.920.830.670.9-0.750.95-0.580.690.730.930.240.92-0.97-0.59-0.47-0.47-0.47
0.970.640.90.220.89-0.220.830.860.190.980.850.910.810.560.91-0.710.89-0.610.650.70.930.480.82-0.94-0.56-0.34-0.34-0.34
0.43-0.220.630.920.150.280.050.420.750.620.420.280.470.070.23-0.10.230.010.370.480.240.480.23-0.30.130.140.140.14
0.860.860.52-0.060.87-0.60.910.92-0.30.780.880.920.90.70.83-0.590.86-0.320.740.860.920.820.23-0.89-0.64-0.46-0.46-0.46
-0.89-0.75-0.720.01-0.930.52-0.84-0.870.1-0.9-0.93-0.87-0.84-0.64-0.830.76-0.990.56-0.68-0.74-0.97-0.94-0.3-0.890.520.610.610.61
-0.7-0.86-0.440.33-0.590.19-0.81-0.510.34-0.41-0.48-0.79-0.43-0.45-0.830.43-0.480.47-0.29-0.29-0.59-0.560.13-0.640.520.10.10.1
-0.23-0.46-0.080.36-0.390.79-0.29-0.370.49-0.27-0.6-0.26-0.38-0.35-0.180.46-0.710.2-0.28-0.35-0.47-0.340.14-0.460.610.11.01.0
-0.23-0.46-0.080.36-0.390.79-0.29-0.370.49-0.27-0.6-0.26-0.38-0.35-0.180.46-0.710.2-0.28-0.35-0.47-0.340.14-0.460.610.11.01.0
-0.23-0.46-0.080.36-0.390.79-0.29-0.370.49-0.27-0.6-0.26-0.38-0.35-0.180.46-0.710.2-0.28-0.35-0.47-0.340.14-0.460.610.11.01.0
Click cells to compare fundamentals
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
Competition

Bioventus Pretax Profit Margin

Pretax Profit Margin

(0.25)

At this time, Bioventus' Pretax Profit Margin is comparatively stable compared to the past year.
Based on the recorded statements, Bioventus has an Operating Margin of 0.0191%. This is 100.05% lower than that of the Health Care Equipment & Supplies sector and 100.05% lower than that of the Health Care industry. The operating margin for all United States stocks is 100.35% lower than that of the firm.

Bioventus Operating Margin Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bioventus' direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Bioventus could also be used in its relative valuation, which is a method of valuing Bioventus by comparing valuation metrics of similar companies.
Bioventus is currently under evaluation in operating margin category among related companies.

Bioventus Fundamentals

About Bioventus Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Bioventus's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bioventus using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bioventus based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the bodys natural healing process in the United States and internationally. The company was founded in 2011 and is headquartered in Durham, North Carolina. Bioventus Inc operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 1160 people.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Bioventus in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Bioventus' short interest history, or implied volatility extrapolated from Bioventus options trading.

Pair Trading with Bioventus

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bioventus position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bioventus will appreciate offsetting losses from the drop in the long position's value.

Moving against Bioventus Stock

  0.81MMSI Merit Medical Systems Financial Report 24th of April 2024 PairCorr
  0.57AHG Akso Health GroupPairCorr
  0.54TFX Teleflex Incorporated Financial Report 2nd of May 2024 PairCorr
  0.42SSY SunLink Health SystemsPairCorr
The ability to find closely correlated positions to Bioventus could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bioventus when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bioventus - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bioventus to buy it.
The correlation of Bioventus is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bioventus moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bioventus moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bioventus can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Bioventus is a strong investment it is important to analyze Bioventus' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Bioventus' future performance. For an informed investment choice regarding Bioventus Stock, refer to the following important reports:
Check out Bioventus Piotroski F Score and Bioventus Altman Z Score analysis.
For more information on how to buy Bioventus Stock please use our How to Invest in Bioventus guide.
You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Complementary Tools for Bioventus Stock analysis

When running Bioventus' price analysis, check to measure Bioventus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioventus is operating at the current time. Most of Bioventus' value examination focuses on studying past and present price action to predict the probability of Bioventus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bioventus' price. Additionally, you may evaluate how the addition of Bioventus to your portfolios can decrease your overall portfolio volatility.
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Is Bioventus' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bioventus. If investors know Bioventus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bioventus listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.54)
Revenue Per Share
8.178
Quarterly Revenue Growth
0.076
Return On Assets
0.0012
Return On Equity
(0.38)
The market value of Bioventus is measured differently than its book value, which is the value of Bioventus that is recorded on the company's balance sheet. Investors also form their own opinion of Bioventus' value that differs from its market value or its book value, called intrinsic value, which is Bioventus' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bioventus' market value can be influenced by many factors that don't directly affect Bioventus' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bioventus' value and its price as these two are different measures arrived at by different means. Investors typically determine if Bioventus is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bioventus' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.